Jubilant Cadista’s September 19, 2025, inspection concluded with zero observations, highlighting top-quality compliance and excellence.

• Jubilant Cadista operates under Jubilant Pharmova, the wholly owned subsidiary of the Jubilant Pharma group entity.
• The inspection, completed on 19 September 2025, closed with no observations, confirming strict standards compliance.
• Jubilant Pharmova globally provides radiopharmaceuticals, allergy immunotherapy, sterile injectables, CRDMO, generics, novel drugs, and services.